Canadian Blood Service

The Canadian Blood Services, while not directly mentioned in the articles, is implicitly relevant as the national authority overseeing blood and plasma collection in Canada. The organization is newsworthy due to the recent deaths of two plasma donors at private clinics in Canada. These clinics are under federal investigation for alleged failures in record-keeping, donor screening, and equipment maintenance. This situation raises concerns about the safety and oversight of plasma donation practices within the Canadian blood system. The incidents highlight a debate regarding the increasing role of private companies in handling blood products, with critics suggesting it represents a decline in a previously robust public system. The Grifols article, while primarily about the company's Biopharma business, mentions their projects in Canada, potentially connecting to the broader context of private sector involvement in the Canadian blood and plasma industry.